Latest Insider Transactions at Cumberland Pharmaceuticals Inc (CPIX)
This section provides a real-time view of insider transactions for Cumberland Pharmaceuticals Inc (CPIX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of CUMBERLAND PHARMACEUTICALS INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of CUMBERLAND PHARMACEUTICALS INC's insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 31
2025
|
Kenneth Krogulski Director |
BUY
Open market or private purchase
|
Direct |
45
+0.02%
|
$180
$4.29 P/Share
|
Mar 31
2025
|
A J Kazimi Chairman and CEO |
BUY
Open market or private purchase
|
Direct |
8
+0.0%
|
$32
$4.29 P/Share
|
Mar 31
2025
|
James Jones Director |
BUY
Open market or private purchase
|
Direct |
8
+0.02%
|
$32
$4.29 P/Share
|
Mar 31
2025
|
Caroline Young Director |
BUY
Open market or private purchase
|
Direct |
4
+0.01%
|
$16
$4.29 P/Share
|
Mar 28
2025
|
Kenneth Krogulski Director |
BUY
Open market or private purchase
|
Direct |
45
+0.02%
|
$180
$4.2 P/Share
|
Mar 28
2025
|
A J Kazimi Chairman and CEO |
BUY
Open market or private purchase
|
Direct |
8
+0.0%
|
$32
$4.2 P/Share
|
Mar 28
2025
|
James Jones Director |
BUY
Open market or private purchase
|
Direct |
8
+0.02%
|
$32
$4.2 P/Share
|
Mar 28
2025
|
Caroline Young Director |
BUY
Open market or private purchase
|
Direct |
4
+0.01%
|
$16
$4.2 P/Share
|
Mar 27
2025
|
Kenneth Krogulski Director |
BUY
Open market or private purchase
|
Direct |
45
+0.02%
|
$180
$4.2 P/Share
|
Mar 27
2025
|
A J Kazimi Chairman and CEO |
BUY
Open market or private purchase
|
Direct |
8
+0.0%
|
$32
$4.2 P/Share
|
Mar 27
2025
|
James Jones Director |
BUY
Open market or private purchase
|
Direct |
8
+0.02%
|
$32
$4.2 P/Share
|
Mar 27
2025
|
Caroline Young Director |
BUY
Open market or private purchase
|
Direct |
4
+0.01%
|
$16
$4.2 P/Share
|
Mar 26
2025
|
Kenneth Krogulski Director |
BUY
Open market or private purchase
|
Direct |
45
+0.02%
|
$180
$4.41 P/Share
|
Mar 26
2025
|
A J Kazimi Chairman and CEO |
BUY
Open market or private purchase
|
Direct |
8
+0.0%
|
$32
$4.41 P/Share
|
Mar 26
2025
|
James Jones Director |
BUY
Open market or private purchase
|
Direct |
8
+0.02%
|
$32
$4.41 P/Share
|
Mar 26
2025
|
Caroline Young Director |
BUY
Open market or private purchase
|
Direct |
4
+0.01%
|
$16
$4.41 P/Share
|
Mar 25
2025
|
Kenneth Krogulski Director |
BUY
Open market or private purchase
|
Direct |
45
+0.02%
|
$180
$4.45 P/Share
|
Mar 25
2025
|
A J Kazimi Chairman and CEO |
BUY
Open market or private purchase
|
Direct |
8
+0.0%
|
$32
$4.45 P/Share
|
Mar 25
2025
|
James Jones Director |
BUY
Open market or private purchase
|
Direct |
8
+0.02%
|
$32
$4.45 P/Share
|
Mar 25
2025
|
Caroline Young Director |
BUY
Open market or private purchase
|
Direct |
4
+0.01%
|
$16
$4.45 P/Share
|
Mar 24
2025
|
Kenneth Krogulski Director |
BUY
Open market or private purchase
|
Direct |
45
+0.02%
|
$180
$4.42 P/Share
|
Mar 24
2025
|
A J Kazimi Chairman and CEO |
BUY
Open market or private purchase
|
Direct |
8
+0.0%
|
$32
$4.42 P/Share
|
Mar 24
2025
|
James Jones Director |
BUY
Open market or private purchase
|
Direct |
8
+0.02%
|
$32
$4.42 P/Share
|
Mar 24
2025
|
Caroline Young Director |
BUY
Open market or private purchase
|
Direct |
4
+0.01%
|
$16
$4.42 P/Share
|
Mar 21
2025
|
Kenneth Krogulski Director |
BUY
Open market or private purchase
|
Direct |
37
+0.01%
|
$148
$4.89 P/Share
|
Mar 21
2025
|
A J Kazimi Chairman and CEO |
BUY
Open market or private purchase
|
Direct |
7
+0.0%
|
$28
$4.89 P/Share
|
Mar 21
2025
|
James Jones Director |
BUY
Open market or private purchase
|
Direct |
7
+0.02%
|
$28
$4.89 P/Share
|
Mar 21
2025
|
Caroline Young Director |
BUY
Open market or private purchase
|
Direct |
3
+0.01%
|
$12
$4.89 P/Share
|
Mar 20
2025
|
Kenneth Krogulski Director |
BUY
Open market or private purchase
|
Direct |
37
+0.01%
|
$185
$5.07 P/Share
|
Mar 20
2025
|
A J Kazimi Chairman and CEO |
BUY
Open market or private purchase
|
Direct |
7
+0.0%
|
$35
$5.07 P/Share
|
Mar 20
2025
|
James Jones Director |
BUY
Open market or private purchase
|
Direct |
7
+0.02%
|
$35
$5.07 P/Share
|
Mar 20
2025
|
Caroline Young Director |
BUY
Open market or private purchase
|
Direct |
3
+0.01%
|
$15
$5.07 P/Share
|
Mar 19
2025
|
Kenneth Krogulski Director |
BUY
Open market or private purchase
|
Direct |
37
+0.01%
|
$185
$5.41 P/Share
|
Mar 19
2025
|
A J Kazimi Chairman and CEO |
BUY
Open market or private purchase
|
Direct |
7
+0.0%
|
$35
$5.41 P/Share
|
Mar 19
2025
|
James Jones Director |
BUY
Open market or private purchase
|
Direct |
7
+0.02%
|
$35
$5.41 P/Share
|
Mar 19
2025
|
Caroline Young Director |
BUY
Open market or private purchase
|
Direct |
3
+0.01%
|
$15
$5.41 P/Share
|
Mar 18
2025
|
Kenneth Krogulski Director |
BUY
Open market or private purchase
|
Direct |
37
+0.01%
|
$185
$5.12 P/Share
|
Mar 18
2025
|
A J Kazimi Chairman and CEO |
BUY
Open market or private purchase
|
Direct |
7
+0.0%
|
$35
$5.12 P/Share
|
Mar 18
2025
|
James Jones Director |
BUY
Open market or private purchase
|
Direct |
7
+0.02%
|
$35
$5.12 P/Share
|
Mar 18
2025
|
Caroline Young Director |
BUY
Open market or private purchase
|
Direct |
3
+0.01%
|
$15
$5.12 P/Share
|
Mar 17
2025
|
Kenneth Krogulski Director |
BUY
Open market or private purchase
|
Direct |
37
+0.01%
|
$185
$5.41 P/Share
|
Mar 17
2025
|
A J Kazimi Chairman and CEO |
BUY
Open market or private purchase
|
Direct |
7
+0.0%
|
$35
$5.41 P/Share
|
Mar 17
2025
|
James Jones Director |
BUY
Open market or private purchase
|
Direct |
7
+0.02%
|
$35
$5.41 P/Share
|
Mar 17
2025
|
Caroline Young Director |
BUY
Open market or private purchase
|
Direct |
3
+0.01%
|
$15
$5.41 P/Share
|
Mar 17
2025
|
Kenneth Krogulski Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+0.88%
|
$25,000
$5.17 P/Share
|
Mar 17
2025
|
Caroline Young Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,000
+3.0%
|
$5,000
$5.17 P/Share
|
Mar 17
2025
|
Martin S Brown Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,000
+10.53%
|
$5,000
$5.17 P/Share
|
Mar 17
2025
|
Joseph C Galante Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,000
+1.59%
|
$5,000
$5.17 P/Share
|
Mar 17
2025
|
James Jones Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,000
+2.29%
|
$5,000
$5.17 P/Share
|
Mar 17
2025
|
A J Kazimi Chairman and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,558
-0.06%
|
$17,790
$5.17 P/Share
|